In Vitro Anti-Parasitic Effects of Scorpion Peptides Smp24 and Smp43 on Trichinella spiralis: Toxicity, Ultrastructural Alterations, Molecular Docking, and Gene Expression.
Scorpion peptides Smp24 and Smp43 just got put through their paces against Trichinella spiralis, the parasite behind trichinellosis. Researchers ran a full battery of in vitro experiments and the results are hard to ignore: these two peptides hammered both adult worms and muscle larvae in a clear, dose-dependent fashion.
Toxicon
by Ibrahim HAM, Hussein AAA, Abdelmaksoud HF et al.
“In Vitro Anti-Parasitic Effects of Scorpion Peptides Smp24 and Smp43 on Trichinella spiralis: Toxicity, Ultrastructural Alterations, Molecular Docking, and Gene Expression. Ibrahim HAM(1), Hussein AAA(2), Abdelmaksoud HF(3), Al-Awadhi RM(4), Elnahas SMM(1), Saleh AM(5), Megahed FAK(6), Abdel-Rahman MA(7), Ayed AS(8). Author information: (1)Zoology Department, Faculty of Science, Suez Canal University, Ismailia, 41522, Egypt. (2)Medical Malacology Department, Theodor Bilharz Research Institute, Giza, Egypt. (3)Parasitology Department, Theodor Bilharz Research Institute, Giza, Egypt. (4)Department of Science, College of Basic Education, The Public Authority for Applied Education and Training (PAAET), Kuwait. (5)Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt. (6)Nucleic Acid Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA City), 21934, Alexandria, Egypt. (7)Zoology Department, Faculty of Science, Suez Canal University, Ismailia, 41522, Egypt. Electronic address: mohamed_hassanain@science.suez.edu.eg. (8)Zoology Department, Faculty of Science, Suez Canal University, Ismailia, 41522, Egypt. Electronic address: aya_abdul-latif@science.suez.edu.eg. Trichinella spiralis is a zoonotic nematode responsible for trichinellosis, a disease with significant public health and economic implications. The current treatment of trichinellosis has limited efficacy, so the development of novel therapeutic agents is essential for effective parasite control. Scorpion venoms contain active compounds, including antimicrobial peptides (AMPs), which have efficacy against a variety of microbes principally through membrane destruction. In this study, the in vitro anti-parasitic effects of Smp24 and Smp43, scorpion venom-derived AMPs, were evaluated against T. spiralis through toxicity assays, ultrastructural analysis, molecular docking, and gene expression profiling. In vitro toxicity assays demonstrated significant inhibitory effects of Smp24 and Smp43 (0-100μg/mL) against adult worms and muscle larvae in a dose- dose-time dependent manner. Ultrastructural SEM analysis after treatment of either Smp24 or Smp43 at LC50 concentrations for 48 hours revealed extensive morphological and structural damage in treated parasites, including disruption of the cuticle, indicating a direct cytotoxic effect. Molecular docking studies predicted strong binding interactions between Smp24, Smp43, and T. spiralis thymidylate synthase, suggesting inhibition of DNA synthesis as a potential mechanism of action. Moreover, gene expression revealed significant upregulation in apoptosis-related genes (Casp3, Casp9, P53) and downregulation of oncogene marker (Ras) in both T. spiralis adult worms and muscle larvae after treatment with the LC50 of Smps peptides, indicating the induction of apoptosis. These findings highlight the potent antiparasitic activity of Smp24 and Smp43 through multiple mechanisms, including direct toxicity, thymidylate synthase inhibition, and apoptotic cell death, suggesting they are promising candidates for controlling T. spiralis infections. Copyright © 2026. Published by Elsevier Ltd. Conflict of interest statement: Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.”
Here’s what stands out:
Toxicity assays showed Smp24 and Smp43 crippled the parasites, and the effect ramped up with higher concentrations and longer exposure.
Scanning electron microscopy revealed the aftermath. Treated worms looked shredded: cuticle damage, structural breakdown, and obvious signs of direct cytotoxicity.
Molecular docking pointed to strong binding between both peptides and thymidylate synthase, a key enzyme in DNA synthesis for the parasite. Translation: these peptides might block parasite replication at the source.
Gene expression profiles told the rest of the story. After peptide treatment, apoptosis-related genes (Casp3, Casp9, P53) spiked, while the Ras oncogene marker dropped. The peptides seem to flip parasite cells into self-destruct mode.
Key takeaway: Smp24 and Smp43 don’t just poke holes in parasites—they hit them from multiple angles. Direct toxicity, possible DNA synthesis disruption, and forced apoptosis. That’s a rare triple-threat for any research peptide.
Trichinellosis is tough to treat with current options. This research puts venom-derived peptides on the map as real contenders for anti-parasitic development. If you’re tracking novel mechanisms or exploring the broader world of anti-parasitic peptide research, this is a serious signal to pay attention. For those interested in sourcing or comparing suppliers, check out our vendor directory.
Bottom line: scorpion venom peptides are delivering results that matter for parasite research. This is where the action is.
Related Reading
The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.
News · J Med ChemStructure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.
News · J Nucl MedCombining an α(v)β(6)-Targeted (177)Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.